Leukotriene B5 (LTB5) is primarily studied for its role in inflammatory processes and immune responses. It is known to act as a signaling molecule in the body, influencing the behavior of white blood cells, particularly neutrophils, during inflammation. LTB5 is often compared to its counterpart, Leukotriene B4 (LTB4), but it tends to exhibit less potent pro-inflammatory effects. This characteristic makes it a subject of interest in research focused on modulating inflammatory diseases, such as arthritis, asthma, and psoriasis. Additionally, LTB5 is being explored for its potential anti-inflammatory properties, which could lead to therapeutic applications in managing chronic inflammatory conditions. Its role in lipid metabolism and its interactions with other lipid mediators are also areas of ongoing investigation, particularly in the context of metabolic disorders and cardiovascular health.